Plus   Neg

STADA FY17 Net Profit Down, Cuts Dividend; Sees Growth Ahead - Quick Facts

STADA Arzneimittel AG (STDAY.PK,STDAF.PK), a pharmaceutical company, reported Thursday that its fiscal 2017 net income reduced 1% to 85.3 million euros from 85.9 million euros last year. Earnings per share were 1.37 euros, down from 1.38 euros a year ago.

Adjusted net income was 195.6 million euros or 3.14 euros per share, compared to 177 million euros or 2.85 euros per share a year ago, mainly reflecting positive development of the operating profit in Belgium, Germany, Spain and Russia.

The adjusted EBITDA increased 9% to 433.9 million euros.

Group sales increased 8% to 2.31 billion euros from prior year's 2.13 billion euros. This rise was mainly due to the increase in the Belgian, Italian and Serbian Generics segment as well as in the Russian Branded Products segment. Group sales adjusted by currency and portfolio effects increased by 6%.

Further, STADA targets to accelerate growth and increase its ranking position in the global pharma market in the coming years. To achieve this target the Executive Board and the Supervisory Board of STADA consider it necessary, to significantly increase investments in R&D, new products, technologies and markets.

Against this backdrop, both bodies suggest to the General Meeting on June 6, 2018, to pay a dividend for the 2017 financial year of 0.11 euro per STADA share, down from previous year's 0.72 euro.

Looking ahead, the Executive Board expects further Group growth for financial year 2018 as compared to the prior year. Group sales adjusted for currency and portfolio effects are expected to be 2.495 billion euros plus or minus 5%, representing a growth in the high single digits adjusted for currency and portfolio effects. Adjusted EBITDA is expected to be 480 million euros plus or minus 5% and adjusted net income 230 million euros plus or minus 5%.

With regard to the strategic outlook for 2019, the Executive Board expects to be able to achieve adjusted Group sales of 2.575 billion euros bn plus or minus 5%, an adjusted EBITDA of 540 million euros plus or minus 5% and adjusted net income of 275 million euros plus or minus 5%.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Saudi Arabia's oil major Aramco is reportedly planning to list its much hyped initial public offering on the Saudi stock market, Tadawu only. Earlier, the Dhahran-based Saudi Arabian national petroleum company was planning for a wider international listing. Following a disastrous week of public-relations fiascoes involving transportation of pets, United Airlines said Tuesday it is suspending its Petsafe program with immediate effect. PetSafe is United Airlines' specially designed program for transporting animals that are not eligible to travel in the aircraft cabin. The program offers airport-to-airport travel for animals to nearly 300 destinations. Chipotle Mexican Grill, the Mexican food-chain that continues to struggle from its food-borne illness scandal, on Tuesday said it has appointed Chris Brandt as its new Chief Marketing Officer to replace Mark Crumpacker, who resigned last week. Most recently, Brandt worked at Bloomin' Brands, where...
comments powered by Disqus
Follow RTT